Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

Discovery & Development Small Molecules

Navigating the Therapeutic Landscape of GERD

06/06/2025 | Rob Coker | 2 min read

A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.

Business & Regulation Business Practice

This Week’s Biopharma News: Argentina’s WHO Exit and Sanofi Acquisition of Blueprint Medicines

06/06/2025 | Rob Coker | 4 min read

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.

Business & Regulation Advanced Medicine

Preparing National Strategies for CAR T: The Latest IQVIA Report

06/05/2025 | Rob Coker | 5 min read

The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies

Discovery & Development Dosage Forms

Psoriasis: More Than Skin Deep

06/04/2025 | Rob Coker | 4 min read

Recent developments in the treatment of psoriasis has brought new hope to sufferers, and a surge in market standings.

Business & Regulation Bioprocessing - Upstream & Downstream

Trump Administration Cans Bird Flu Vaccine Contract With Moderna

05/30/2025 | Rob Coker | 3 min read

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.

Business & Regulation Business Practice

This Week’s Biopharma News: Pfizer and Astellas Drug Improves Cancer Survival

05/30/2025 | Rob Coker | 4 min read

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

Discovery & Development Drug Discovery

Eli Lilly and Purdue Expand Partnership with $250 Million Investment

05/19/2025 | Rob Coker | 2 min read

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.

Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

05/16/2025 | Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Discovery & Development Analytical Science

Cracking the Code of Phages and How They Can Fight TB

05/15/2025 | Rob Coker | 2 min read

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.

Business & Regulation Advanced Medicine

This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened

05/15/2025 | Rob Coker | 4 min read

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity